Experimental studies have demonstrated that overexpression of MBNL1-AS1 reduces cell proliferation, tumorigenic capacity, self-renewal and the expression of stemness markers in basal breast cancer cells. This evidence concerns the gene MBNL1 and breast carcinoma.